Erratum: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy (SLEEP DOI: 10.1093/sleep/zsaa206)

Richard K. Bogan, Michael J. Thorpy, Yves Dauvilliers, Markku Partinen, Rafael Del Rio Villegas, Nancy Foldvary-Schaefer, Roman Skowronski, Lihua Tang, Franck Skobieranda, Karel Šonka

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the originally published version of this article, one reference had been inadvertently omitted. A corrected reference list is provided and the numbering of references within the article body is unaffected. This has now been corrected online.

Original languageEnglish (US)
Article numberzsab188
JournalSleep
Volume44
Issue number11
DOIs
StatePublished - Nov 1 2021

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Erratum: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy (SLEEP DOI: 10.1093/sleep/zsaa206)'. Together they form a unique fingerprint.

Cite this